Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
医学
卵巢癌
肿瘤科
内科学
妇科
癌症
作者
Giorgio Valabrega,Bhavana Pothuri,Ana Oaknin,Whitney S. Graybill,Ana Beatriz Sánchez,Colleen McCormick,Jean‐François Baurain,Anna V. Tinker,Hannelore Denys,Roisin E. O’Cearbhaill,Sakari Hietanen,Richard G. Moore,Anja Ør Knudsen,Thibault de La Motte Rouge,Florian Heitz,Tally Levy,Whitney York,Divya Gupta,Bradley J. Monk,Antonio González‐Martín
To evaluate the impact of age on the efficacy and safety of niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer with a complete/partial response to first-line platinum-based chemotherapy.
杳鸢
WUWUWU
Billy
嗯哼
洛洛大方
shinysparrow
梁朝伟
cocolu
xchqb
暴躁的寻云
科目三
sissiarno
青羽凌雪
粗犷的灵松
tuanheqi
从容芮
蒋时晏
完美世界
xy
CUT
皖公网安备34019202002308
